Effect of Quercetin on the Plasma and Intracellular Concentrations of Saquinavir in Healthy Adults
Authors:
- 1 September 2006
- journal article
- clinical trial
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 26 (9) , 1255-1261
Abstract
Study Objectives. To determine if quercetin, a bioflavonoid that inhibits p‐glycoprotein, alters plasma saquinavir concentrations, and to explore the potential influence on intracellular concentrations.Design. Prospective pharmacokinetic analysis.Setting. University‐affiliated general clinical research center.Subjects. Ten healthy adults (four women, six men) with a mean ± SD age of 30.7 ± 9.4 years.Intervention. All subjects received saquinavir 1200 mg 3 times/day with food on days 1–11 and quercetin 500 mg 3 times/day with food on days 4–11.Measurements and Main Results. On days 4 and 11, nine blood samples and four peripheral blood mononuclear cell samples were drawn during a steady‐state dosing interval. Pharmacokinetic parameters were calculated by using standard noncompartmental techniques. Plasma saquinavir concentrations were similar regardless of quercetin administration. Geometric mean ratios for the area under the concentration‐time curve during an 8‐hour dosing interval (AUC0–8), maximum concentration in the dosing interval, and minimum concentration in the dosing interval were 0.99 (95% confidence interval [CI] 0.65–1.50), 0.99 (95% CI 0.64–1.54), and 1.06 (95% CI 0.68–1.67), respectively. Intracellular saquinavir concentrations displayed substantial intra‐ and intersubject variability, which limited the ability to determine the influence of quercetin coadministration (geometric mean ratio for AUC0–8 = 0.51 [95% CI 0.14–1.95], six patients).Conclusion. Quercetin coadministration did not influence plasma saquinavir concentrations. Because of substantial inter‐ and intrasubject variability, more study is necessary to determine if saquinavir intracellular concentrations are altered by coadministration of quercetin.Keywords
This publication has 29 references indexed in Scilit:
- Liquid chromatography–tandem mass spectroscopy assay for quercetin and conjugated quercetin metabolites in human plasma and urineJournal of Chromatography B, 2005
- Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetinEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Direct Evidence that Saquinavir Is Transported by Multidrug Resistance-Associated Protein (MRP1) and Canalicular Multispecific Organic Anion Transporter (MRP2)Antimicrobial Agents and Chemotherapy, 2002
- The Effect of Garlic Supplements on the Pharmacokinetics of SaquinavirClinical Infectious Diseases, 2002
- Inhibition of the CYP3A4‐mediated metabolism and P‐glycoprotein‐mediated transport of the HIV‐1 protease inhibitor saquinavir by grapefruit juice componentsBritish Journal of Clinical Pharmacology, 1999
- Stimulation of P‐glycoprotein‐mediated drug transport by prazosin and progesteroneEuropean Journal of Biochemistry, 1999
- Positively Cooperative Sites for Drug Transport by P‐Glycoprotein with Distinct Drug SpecificitiesEuropean Journal of Biochemistry, 1997
- Zidovudine Induces the Expression of Cellular Resistance Affecting Its Antiviral ActivityAIDS Research and Human Retroviruses, 1994
- Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinaseAntiviral Research, 1991
- Human immunodeficiency virus I-induced expression of P-glycoproteinBiochemical and Biophysical Research Communications, 1990